Zydus Cadila net profit rises 41 percent to Rs 527 crore in Q3 Ruchika Sharma8 Feb 2021 10:00 AM ISTAhmedabad: Pharmaceutical major Zydus Cadila said on Friday its profit after tax was up by 41 per cent to Rs 527 crore in Q3 FY21 as compared to the...
AstraZeneca gets CDSCO nod for Dapagliflozin in CKD MD Bureau17 Jan 2021 3:30 PM ISTNew Delhi: The Subject Expert Committee (SEC), operative under the Central Drugs Standard Control Organization (CDSCO), has given its nod to...
Dapagliflozin going off-patent- NPPA brings Dapagliflozin, Metformin Combination under price control Farhat Nasim14 Jan 2021 5:15 PM ISTNew Delhi: With the popular antidiabetic drug, Dapagliflozin going off-patent, the apex drug price regulator, National Pharmaceutical Pricing...
NPPA fixes retail price of 7 formulations, Details Ruchika Sharma9 Jan 2021 3:24 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India...
AstraZeneca gets USFDA Priority Review for Farxiga to treat chronic kidney disease Ruchika Sharma7 Jan 2021 12:00 PM ISTCKD, a condition defined by decreased kidney function, is often associated with a heightened risk of heart disease or stroke, or the need for dialysis...
No impact of dapagliflozin on short-term BP variability in diabetics: Study Medha Baranwal10 Dec 2020 10:30 AM ISTGreece: The use of SGLT2 inhibitor dapagliflozin does not affect short-term blood pressure variability (BPV) in type 2 diabetes (T2D) patients,...
Dapagliflozin, metformin, or exercise didn't decrease plasma glucagon in individuals with prediabetes Dr. Nandita Mohan25 Nov 2020 12:30 PM ISTResearchers have found that in individuals with prediabetes, 13 weeks of treatment with dapagliflozin, metformin, or exercise was not associated...
Dapagliflozin NOT off Patent, says AstraZeneca Medical Dialogues Bureau23 Nov 2020 3:14 PM ISTNew Delhi: The arrival of SGLT-2 inhibitors or Glifozins, has brought a major change in the management of Diabetes in the past decade. Numerous pharma...
Dapagliflozin effectively reduces blood sugar and weight in type 1 diabetes: Study Medha Baranwal11 Nov 2020 11:15 AM ISTDelhi: A recent study evaluating dapagliflozin for the treatment of patients with type 1 diabetes (T1D) has yielded positive results. According to the...
Drug combo controls blood sugar, weight and BP in Diabetics: Study Dr. Kamal Kant Kohli3 Nov 2020 12:00 PM ISTPHILADELPHIA - Researchers at Thomas Jefferson University have found in a new multi-center double-blind, phase 3, randomized controlled trial that ...
Dapagliflozin Going Off Patent with a Slashed Price Hina Zahid3 Nov 2020 11:30 AM ISTDiabetes is well-known to adversely impact the heart, vascular system and renal system. The patients with type 2 diabetes mellitus (T2DM) are at...
Price war over Diabetes drug Dapagliflozin: AstraZeneca drags 12 drugmakers to Delhi court Farhat Nasim16 Oct 2020 5:30 PM ISTNew Delhi: Proclaiming a legal battle against 12 Indian drugmakers, AstraZeneca has moved Delhi high court against the dozen firms for eyeing to roll...
